Kissei Pharmaceutical (Japan)
In research, Kissei Pharmaceutical (Japan) stands highest in Medicine (#11,925 of 17,978 worldwide), Life Sciences (#9,570 of 14,347 worldwide) and Health Sciences (#15,011 of 20,462 worldwide), over all time.
- World rank, all time
- #21,499 of 42,892
- Rank in Japan
- #810 of 2,112
- Research works
- 578 ▼ 11% vs 2013–17
- Citations
- 13k 22.7 per fractional work
- Top-10% rate
- 10.3% record average 16.5%
- Open access
- 54% world 28%
What is Kissei Pharmaceutical (Japan) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #11,925 of 17,978 | 13.2% | 262 | |
| Life SciencesDomain | #9,570 of 14,347 | 8.8% | 226 | |
| Health SciencesDomain | #15,011 of 20,462 | 12.8% | 275 | |
| Biochemistry, Genetics and Molecular BiologyField | #7,300 of 7,814 | 9.0% | 122 |
Each strip is that field’s whole ranked pool, with the notch where Kissei Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.1×. Every wedge is a field page.
Who are the top researchers at Kissei Pharmaceutical (Japan)?
Ranked on the composite score, Hiroshi Kusama, Masuo Akahane and Arao Ujiie lead among researchers whose main affiliation is Kissei Pharmaceutical (Japan).
- 1 Hiroshi Kusama Japan · #424,317 worldwide 29 citations · 21 works
- 2 Masuo Akahane Japan · #442,539 worldwide 75 citations · 19 works
- 3 Arao Ujiie Japan · #1,246,525 worldwide 17 citations · 21 works
- 4 Mamoru Kobayashi Japan · #1,418,363 worldwide 8 citations · 39 works
- 5 Jun Naito Japan · #1,477,670 worldwide 27 citations · 26 works
Which keywords describe research at Kissei Pharmaceutical (Japan)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Urinary Incontinence, Epidemiology, Mitochondrial Dysfunction, Insulin Resistance, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Quality of Life and Metabolic Regulation.
- Receptor
- Metabolic Syndrome
- Estrogen
- Cardiovascular Disease
- Genetics
- Depression
- Pelvic Floor Dysfunction
- Infertility
- Diagnosis
- Brown Adipose Tissue
- Metabolic Regulation
- Lower Urinary Tract Symptoms
- Insulin Resistance
- Urinary Incontinence
- Epidemiology
- Mitochondrial Dysfunction
- Benign Prostatic Hyperplasia
- Quality of Life
- Surgical Treatment
- Thermogenesis
- Inflammation
- Oxidative Stress
- Pelvic Organ Prolapse
- Stress
- Signaling
- Differentiated Thyroid Cancer
- Management
- Pathophysiology
- Thyroid Nodules
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Epidemiology4▲ 3.9×10 topics
- Urinary Incontinence4▲ 170×2 topics
- Mitochondrial Dysfunction3▲ 33×4 topics
- Insulin Resistance2▲ 20×3 topics
- Benign Prostatic Hyperplasia2▲ 272×1 topic
- Lower Urinary Tract Symptoms2▲ 272×1 topic
- Quality of Life2▲ 5.9×4 topics
- Metabolic Regulation2▲ 43×2 topics
- Surgical Treatment2▲ 36×2 topics
- Brown Adipose Tissue2▲ 118×1 topic
- Thermogenesis2▲ 118×1 topic
- Diagnosis2▲ 5.6×7 topics
- Inflammation1▲ 2.4×8 topics
- Infertility1▲ 34×2 topics
- Oxidative Stress1▲ 2.9×4 topics
- Pelvic Floor Dysfunction1▲ 99×1 topic
- Pelvic Organ Prolapse1▲ 99×1 topic
- Depression1▲ 4.8×2 topics
- Stress1▲ 11×2 topics
- Genetics1▲ 5.9×4 topics
- Signaling1▲ 69×2 topics
- Cardiovascular Disease1▲ 3.2×2 topics
- Differentiated Thyroid Cancer1▲ 92×1 topic
- Estrogen1▲ 96×1 topic
- Management1▲ 4.8×4 topics
- Metabolic Syndrome1▲ 4.4×2 topics
- Pathophysiology1▲ 12×3 topics
- Receptor1▲ 112×1 topic
- Thyroid Nodules1▲ 92×1 topic
Which research topics does Kissei Pharmaceutical (Japan) publish most on?
By volume in 2022–2025: Urinary Bladder and Prostate Research, Adipose Tissue and Metabolism, Pelvic floor disorders treatments and Thyroid Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Urinary Bladder and Prostate Research Urology 2 works
- 2 Adipose Tissue and Metabolism Physiology 2 works
- 3 Pelvic floor disorders treatments Rheumatology 1 works
- 4 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 1 works
- 5 Estrogen and related hormone effects Genetics 1 works
- 6 Urinary Tract Infections Management Epidemiology 1 works
- 7 Ovarian function and disorders Reproductive Medicine 1 works
- 8 Ion Channels and Receptors Sensory Systems 1 works
- 9 Hypothalamic control of reproductive hormones Reproductive Medicine 1 works
- 10 Endometriosis Research and Treatment Reproductive Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kissei Pharmaceutical (Japan)'s research output changed?
Output in 2018–2022 was 11% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Matsumoto
- Shinshu University
- Shinshu University Hospital
- Aizawa Hospital
- Matsumoto University
- Matsumoto City Hospital
- Matsumoto Junior College
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.